Chris Nevala (@chrisnevala) 's Twitter Profile
Chris Nevala

@chrisnevala

GI medical oncologist at U of Utah

ID: 1193334349367635969

calendar_today10-11-2019 01:07:48

4 Tweet

77 Takipçi

117 Takip Edilen

Utah IM CMRs (@utahimcmrs) 's Twitter Profile Photo

👏💪👊 Strong work Dr. Laura Miotke PGY-3 and rising VA #CRQS on her work differentiating recurrent vs. de-novo pancreatic cancer with mentorship from Dr Ignacio Garrido-Laguna Huntsman Cancer Institute journalofclinicalpathways.com/multimedia/rea… #MedicineElevatedResearch #WIM #UtahWIM

Journal of the @NCCN (@jnccn) 's Twitter Profile Photo

Publication Alert: Clinical Activity of #Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to #Entrectinib: buff.ly/3ueQSK4 Vaia Florou, MD Ignacio Garrido-Laguna Chris Nevala Huntsman Cancer Institute #hncsm #NTRK #NTRKfusion

Publication Alert: Clinical Activity of #Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to #Entrectinib: buff.ly/3ueQSK4 <a href="/VaiaFlorou/">Vaia Florou, MD</a> <a href="/GarridoLagunaMD/">Ignacio Garrido-Laguna</a> <a href="/ChrisNevala/">Chris Nevala</a> <a href="/huntsmancancer/">Huntsman Cancer Institute</a> #hncsm #NTRK #NTRKfusion
Journal of the @NCCN (@jnccn) 's Twitter Profile Photo

Treatment Trends and Clinical Outcomes of Left-Sided RAS/RAF Wild-Type Metastatic #ColorectalCancer in the United States: buff.ly/33aftrU by Ignacio Garrido-Laguna Chris Nevala Drew Trunk, MD and colleagues at Huntsman Cancer Institute #CRCSM #hsronc

Treatment Trends and Clinical Outcomes of Left-Sided RAS/RAF Wild-Type Metastatic #ColorectalCancer in the United States: buff.ly/33aftrU by <a href="/GarridoLagunaMD/">Ignacio Garrido-Laguna</a> <a href="/ChrisNevala/">Chris Nevala</a> <a href="/DTrunkMD/">Drew Trunk, MD</a> and colleagues at <a href="/huntsmancancer/">Huntsman Cancer Institute</a>
#CRCSM #hsronc
Pashtoon Kasi MD, MS (@pashtoonkasi) 's Twitter Profile Photo

Gabriel Brooks ASCO Chiara Cremolini OncoAlert #ASCO22 worth noting some recent real 🌎 🇺🇸 data on patients with #colorectalcancer who got EGFR⛔️ 🆚 VEGF⛔️ It crosses 42 months! Sequencing upfront is relevant. Not just in terms of biologics; but also: Triplet 🆚 Doublet #CRCSM Good derm followup. 💡 💊 Amiloride.

<a href="/gabe_a_brooks/">Gabriel Brooks</a> <a href="/ASCO/">ASCO</a> <a href="/ChiaraCrem1/">Chiara Cremolini</a> <a href="/OncoAlert/">OncoAlert</a> #ASCO22 worth noting some recent real 🌎 🇺🇸 data on patients with #colorectalcancer who got

EGFR⛔️
🆚 
VEGF⛔️

It crosses 42 months! 

Sequencing upfront is relevant. Not just in terms of biologics; but also:

Triplet
🆚
Doublet

#CRCSM 
Good derm followup.
💡 💊 Amiloride.